Most Recent Additions*
Addressing a By-Product of the Opioid Addiction Crisis: Commercial Sexual Exploitation
Nicole Bell, Marianne M. Sarkis, and Susan Halpin
Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasia
Jildaz Caroff, Takamitsu Tamura, Robert M. King, Pedro N. Lylyk, Erin T. Langan, Olivia W. Brooks, Frederic Clarencon, John Michael. Wainwright, Laurent Spelle, Miklos G. Marosfoi, Matthew J. Gounis, and Ajit S. Puri
A microtubule-dynein tethering complex regulates the axonemal inner dynein f (I1)
Tomohiro Kubo, Yuqing Hou, Deborah A. Cochran, George B. Witman, and Toshiyuki Oda
Making the Case for Sustainable Funding for Community Health Worker Services: Talking to Payers and Providers
Katharine London
A Budget Impact Model for Two Investigational Agents for the Treatment of Nonalcoholic Steatohepatitis
Nicole M. Trask, Pavel Lavitas, and Vincent Palumbo
Impact of a Pilot Outreach Program upon Provider Awareness and Prescribing of a Concerning Opioid Combination Regimen
Briana Santaniello, Thomas C. Pomfret, Mark A. Tesell, Nicole M. Trask, Caroline J. Alper, Karen M. Clements, Vincent Palumbo, Kimberly Lenz, and Paul L. Jeffrey
New payment methods and delivery system reforms can support sustainable funding for community health worker services
Katharine London
A Medicaid compromise expanded coverage for Hoosiers, but important questions linger
Robert W. Seifert
LTSS clinical guidelines help health plans navigate the challenges of increased demand
Jessica Carpenter
Policy Brief: Addressing Social Determinants of Health through Community Health Workers: A Call to Action
Katharine London, Grace Damio, Meredith Ferrazo, Rafael Perez-Escamalla, and Noelle Wiggins
Elliot Hospital Fact Sheet: Prepared for the New Hampshire Office of the Attorney General Charitable Trusts Unit
Katharine London and
A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy
Takako I. Jones and Peter L. Jones
Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach
Keitaro Fukuda and Takeru Funakoshi
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
Shahrad Hakimian, Yevgeniy Popov, Abbas Rupawala, Karen I. Salomon-Escoto, Steven Hatch, and Randall Pellish
The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
Maria Perez Carrion, John E. Landers, Stefano Goldwurm, and Giovanni Piccoli
Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation
Maria L. Allende, Emily K. Cook, Bridget C. Larman, Adrienne Nugent, Jacqueline M. Brady, Diane Golebiowski, Miguel Sena-Esteves, Cynthia J. Tifft, and Richard L. Proia
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
Minan Wang, Michael A. Brehm, and Dale L. Greiner
*Updated as of 04/22/18.